RankAlpha logo
Back to Rankings

BFRI

BiofronteraF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
BFRI vs peer average
40/100
BFRI vs. peer average (F vs. D)
Grade spread
D 5 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

CELU is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $20.15M

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerCELUCelularity
BFRI
Biofrontera
CELU
Celularity
Grade
F
D
Momentum
18
55
Value
41
41
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs CELU

BFRI / CELU
Grade Position
Below peers
BFRI vs. peer average (F vs. D)
40/100
Momentum
18
CELU
Value
41
BFRI
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BFRI
1
CELU
Celularity Inc Class A Common
D
40/100
-1
2
HOWL
Werewolf Therapeutics Inc Common
D
40/100
-1
3
MRKR
Marker Therapeutics Inc Common
D
40/100
-1
4
NEUP
Neuphoria Therapeutics Inc Common
D
40/100
-1
5
COCP
Cocrystal Pharma Inc Common
F
20/100
Even
CELU is the first peer returned for this comparison set.